跳至主要内容
临床试验/TCTR20210730002
TCTR20210730002已完成4 期

Bronchodilator effect of oral doxofylline and procaterol in asthma : A randomized crossover study

Faculty of Medicine, Thammasat University0 个研究点目标入组 21 人开始时间: 2021年7月30日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
21

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age 18 years or more, 2. asthma diagnosis based on criteria of Global Initiative for Asthma (GINA), 3. Treatment with inhaled corticosteroid (ICS) or ICS plus long-acting beta2-agonists (ICS/LABA)

排除标准

  • 1. Smoking 10 pack-years or more, 2. Inability to perform spirometry, 3. FEV1 50% or less, 4. Asthma exacerbation within 3 months, 5. Treatment with systemic corticosteroid within 3 months, 6. Treatment with monoclonal anti-IgE (omalizumab) within 3 months, 7. Treatment with Salbutamol, Procaterol, Theophylline, Doxofylline within 1 week, 8. One of the following diseases or conditions: lung fibrosis, cardiac arrhythmia, chronic kidney disease (GFR<50 mL/min), chronic liver disease (AST, ALT, bilirubin, alkaline phosphatase, or GGT 1.5 x upper limit of normal), active malignancy, uncontrolled hypertension (blood pressure 200/100 mmHg or more), thyrotoxicosis, 9. preganancy or lactation

研究者

发起方
Faculty of Medicine, Thammasat University

相似试验

Bronchodilator effect of oral doxofylline and... | 临床试验